188 related articles for article (PubMed ID: 35585570)
41. Aqueous Humor Cytokines in Non-Proliferative Diabetic Retinopathy.
Obadă O; Pantalon AD; Rusu-Zota G; Hăisan A; Lupuşoru SI; Constantinescu D; Chiseliţă D
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888628
[TBL] [Abstract][Full Text] [Related]
42. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy.
Lu Q; Lu L; Chen B; Chen W; Lu P
Can J Ophthalmol; 2019 Jun; 54(3):291-296. PubMed ID: 31109466
[TBL] [Abstract][Full Text] [Related]
43. Aqueous humor monocyte chemoattractant protein-1 predicted long-term visual outcome of proliferative diabetic retinopathy undergone intravitreal injection of bevacizumab and vitrectomy.
Lei J; Ding G; Xie A; Hu Y; Gao N; Fan X
PLoS One; 2021; 16(3):e0248235. PubMed ID: 33667285
[TBL] [Abstract][Full Text] [Related]
44. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
45. Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients.
Xu Y; Xie C; Fang Y; Yu Y; Qiu C
Int J Ophthalmol; 2022; 15(10):1619-1626. PubMed ID: 36262859
[TBL] [Abstract][Full Text] [Related]
46. Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.
Forooghian F; Kertes PJ; Eng KT; Agrón E; Chew EY
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2388-92. PubMed ID: 20007836
[TBL] [Abstract][Full Text] [Related]
47. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
Li S; Guo L; Zhou P; Tang J; Wang Z; Zhang L; Zhao M; Qu J
Eye Vis (Lond); 2022 Dec; 9(1):44. PubMed ID: 36451252
[TBL] [Abstract][Full Text] [Related]
48. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab.
Matsuyama K; Ogata N; Jo N; Shima C; Matsuoka M; Matsumura M
Jpn J Ophthalmol; 2009 May; 53(3):243-8. PubMed ID: 19484443
[TBL] [Abstract][Full Text] [Related]
49. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
Li S; Yang Y; Zou J; Zeng J; Ding C
BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
[TBL] [Abstract][Full Text] [Related]
50. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
51. Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
Chen GH; Tzekov R; Mao SH; Tong YH; Jiang FZ; Li WS
Eye (Lond); 2022 Mar; 36(3):619-626. PubMed ID: 33824510
[TBL] [Abstract][Full Text] [Related]
52. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.
Roh MI; Kim HS; Song JH; Lim JB; Kwon OW
Ophthalmology; 2009 Jan; 116(1):80-6. PubMed ID: 19118699
[TBL] [Abstract][Full Text] [Related]
53. Surgical Treatment of Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy in Japanese Patients without the Use of Glaucoma Drainage Devices.
Takeuchi M; Kanda T; Harimoto K; Sora D; Okazawa R; Sato T
J Clin Med; 2024 May; 13(11):. PubMed ID: 38892963
[No Abstract] [Full Text] [Related]
54. Relationship Between Aqueous Humor Levels of Cytokines and Axial Length in Patients With Diabetic Retinopathy.
Hong F; Yang DY; Li L; Zheng YF; Wang XJ; Guo SRN; Jiang S; Zhu D; Tao Y
Asia Pac J Ophthalmol (Phila); 2020; 9(2):149-155. PubMed ID: 31985528
[TBL] [Abstract][Full Text] [Related]
55. Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy.
Cheung CM; Vania M; Ang M; Chee SP; Li J
Mol Vis; 2012; 18():830-7. PubMed ID: 22511846
[TBL] [Abstract][Full Text] [Related]
56. Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema.
Wei Q; Wan Z; Hu Y; Peng Q
Drug Des Devel Ther; 2019; 13():4367-4374. PubMed ID: 31920286
[TBL] [Abstract][Full Text] [Related]
57. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
58. A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy.
Yang X; Xu J; Wang R; Mei Y; Lei H; Liu J; Zhang T; Zhao H
J Ophthalmol; 2016; 2016():2473234. PubMed ID: 27034822
[TBL] [Abstract][Full Text] [Related]
59. Effects of ranibizumab on growth factors and mediators of inflammation in the aqueous humor of patients with diabetic macular edema.
Utsumi T; Noma H; Yasuda K; Goto H; Shimura M
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2597-2603. PubMed ID: 33772356
[TBL] [Abstract][Full Text] [Related]
60. Level of vascular endothelial growth factor in aqueous humor and surgical results of ahmed glaucoma valve implantation in patients with neovascular glaucoma.
Kim YG; Hong S; Lee CS; Kang SY; Seong GJ; Ma KT; Kim CY
J Glaucoma; 2009 Aug; 18(6):443-7. PubMed ID: 19680051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
